Myocardial ischemia resulted from blockade in the coronary arteries caused by atherosclerosis can impair oxygen delivery [1] . , a proximal signalling receptor in innate immune response, is also expressed in heart and vasculature [2] 
modulation of TLR4-mediated signalling protects the myocardium from ischemic injury remain unclear.
The AMP-activated protein kinase (AMPK) is an energy-sensing enzyme that can be activated by ischemia [1, 9, 10] , and we have found that AMPK plays an important role in cardioprotection against ischemic injury [11, 12] . AMPK mediates several metabolic changes such as decreasing fatty acid and cholesterol synthesis, inhibiting hepatic glucose production and increasing fatty acid oxidation and muscle glucose uptake [13, 14] . In cardiac muscle, AMPK activity is increased by stimuli such as exercise, hypoxia, ischemia and stress [11] . It plays a central role in monitoring the cellular energy status and controlling energy production and consumption [13, 15, 16] . Intriguingly, it has been reported that AMPK protects cardiomyocytes against hypoxic injury by attenuation of endoplasmic reticulum (ER) stress [17] . In eukaryotic cells, the ER plays a vital role in the maturation, processing and transporting secretory-and membrane-associated proteins [8] . The ER is exquisitely sensitive to alteration in homeostasis, with perturbations in the environment resulting in a condition known as ER stress [18] . 
Here we examined whether the cardioprotection of TLR4-mutated hearts against ischemic injury is mediated by AMPK signalling pathways and what's the role of TLR4 downstream, the MAPK signalling pathway in the cardioprotective effect. We also try to address the relationship between ischemic stress and ER stress in the heart. Interestingly, the TLR4-mutated C3H/HeJ hearts displayed resistance to ischemic stress than wild-type (WT) C3H/HeN hearts, which is linked to higher AMPK and ERK activation and lower p38 and JNK activation. C3H/HeJ hearts also demonstrated less ER stress status than C3H/HeN hearts, as indicated by ER

Materials and methods
Animals and surgical procedures
Myocardial infarct size measurement
Mice were anesthetized, intubated and ventilated with respirator [9, 19] 
Isolation of mouse cardiomyocytes
Cardiomyocytes were enzymatically isolated as described previously [20] . [22] .
AMPK activity and phosphorylation
AMPK activity was measured with the synthetic SAMS peptide [9, 19] after immuno-isolation with AMPK-␣ subunit antibody [9, 19, 23] [9, 19] .
Immunoblotting
Immunoblots were performed as previously described [19, 24] . Fig. 2A and B) . (Fig. 3A-C) . Intriguingly, p38 and JNK signalling were blunted in C3H/HeJ hearts compared to C3H/HeN hearts during ischemia (Fig. 3A and B) . In contrast, ERK signalling was enhanced in C3H/HeJ hearts compared to C3H/HeN hearts during ischemia (Fig. 3C ).
Analysis of myocyte apoptosis
Moreover, the phosphorylation of the AMPK downstream targets, ACC and eukaryotic elongation factor 2 (eEF2), were also enhanced in C3H/HeJ hearts compared to C3H/HeN hearts (Fig. 2C and D).
Impaired activation of MAPK signalling in C3H/HeN versus C3H/HeJ during ischemia
Resistance to cardiac ER stress in TLR4-mutated heart during ischemia (Fig. 3D) , while up-regulation in all these ER stress makers was blunted in C3H/HeJ hearts during ischemia (Fig. 3D ). Fig. 4E and F) . Interestingly, the hypoxia-induced mechanical dysfunction in C3H/HeN cardiomyocytes was significantly attenuated by TLR4 mutation in C3H/HeJ cardiomyocytes (Fig. 4) , suggesting a beneficial role of TLR4 deficiency in cardiac protection against hypoxia-induced cardiac dysfunction. (Fig. 4F) . Fig. 7B and C) . Therefore, TLR4 mutation leads to cardiac [7] , while it enhanced ischemic activation of the ERK survival signalling pathway [7] . [37] . Our group and others have reported that ischemic activation of p38, one of the TLR4 downstream effectors, plays an important role in regulation of glucose uptake [9] and cardioprotection against ischemic injury [38, 39] . Though there were several studies support the view that p38 is a downstream of AMPK signalling [9, 11] , controversy of their relationship also can be considered [40] . There were studies which demonstrated that although AMPK and p38 were both activated during myocardial ischemia, the activation of p38 occurs independently of AMPK [18, 24] . JNK activation has a pro-apoptotic effect under various cell death-inducing stimuli, such as oxidative stress and DNA damaging agents [43, 44] . Also, using a highly specific peptide inhibitor of JNK, Milano et al. [45] showed that inhibition of JNK reduces myocardial ischemic-reperfusion injury and infarct size in anesthetized rats in vivo. On the other hand, ERK activation is antiapoptotic in most tissues [46] 
TLR4-mutated mitigates ischemic contractile dysfunction of cardiomyocytes
Fig. 3 Effects of TLR4 functional deficiency on ischemia-induced mitogen-activated protein kinases (MAPKs) and cardiac ER stress. Time course of p38 (A), JNK (B) and ERK (C) phosphorylation induced by in vivo regional ischemia or sham operation, in C3H/HeN and C3H/HeJ hearts. Immunoblots were performed with antibodies for phosphor-p38 (Thr180/Tyr182) (p-p38), total p38 (p38), phosphor-JNK (Thr183/Tyr185) (p-JNK), total JNK (JNK), phosphor-ERK (Thr202/Tyr204) (p-ERK) or total ERK (ERK). The graph shows phosphorylated p38 MAPK (A), phosphorylated JNK (B) and phosphorylated ERK (C) relative to the total amount of respective kinases. (D) The representative immunoblots show that ischemic stress (30 min.) stimulated the upregulation of ER chaperons, Grp78/BiP and Gadd153/CHOP and ER integral membrane protein, IRE-1␣. Immunoblots were performed with antibodies for Grp78/BiP, Gadd153/CHOP, IRE-1␣ or GAPDH. The graph shows the relative expression levels of Grp78/BiP, Gadd153/CHOP or IRE-1␣ to the GAPDH expression. Values are mean Ϯ S.E.M. for five experiments. *P Ͻ 0.05 versus sham, †P Ͻ 0.05 versus C3H/HeN ischemic time-points, respectively.
Fig. 2 Differential cardiac AMPK activation in C3H/HeN versus C3H/HeJ mice during ischemia. (A) Time course of AMPK phosphorylation induced by in vivo regional ischemia or control sham operation. Immunoblots were performed with antibodies for phosphor-AMPK (Thr172) (p-AMPK) or pan-␣ AMPK (AMPK-␣). The graph shows phosphorylated AMPK relative to the total amount of kinase. (B) AMPK activity in C3H/HeN and C3H/HeJ hearts after sham operations or in vivo regional ischemia. (C) Phosphorylation of AMPK downstream ACC and (D) Phosphorylation of AMPK downstream eEF2 induced by in vivo regional
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Fig. 4 Contractile properties of cardiomyocytes from C3H/HeN and C3H/HeJ hearts during hypoxia (30 min.). (A) Resting cell length; (B) Peak shortening (PS, normalized to cell length)l; (C) and (D), Maximal velocity of shortening (ϩdl/dt) and relengthening (-dl/dt); (E) Time-to-PS (TPS); (F) Time-to-90% relengthening (TR90). Values are mean Ϯ S.E.M., n ϭ 60-90 cells per group, *P Ͻ 0.05 versus control, respectively, †P Ͻ 0.05 versus C3H/HeN hypoxia.
Fig. 5 Effects of TLR4 functional deficiency on hypoxia-induced phosphorylation of AMPK and ERK in cardiomyocytes. The representative immunoblots show that hypoxia (30 min.) stimulated phosphorylation of AMPK (A) and ERK (B) in C3H/HeN and C3H/HeJ cardiomyocytes. Immunoblots were performed with antibodies for phosphor-AMPK (Thr172) (p-AMPK), pan-␣ AMPK (AMPK-␣), phosphor-ERK (Thr202/Tyr204) (p-ERK) or total ERK (ERK). The graph shows phosphorylated AMPK (A), phosphorylated ERK (B) relative
